Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Net Margin (2016 - 2025)

Fortress Biotech (FBIO) has 12 years of Net Margin data on record, last reported at 21.59% in Q3 2025.

  • For Q3 2025, Net Margin rose 12440.0% year-over-year to 21.59%; the TTM value through Sep 2025 reached 95.94%, up 204254.0%, while the annual FY2024 figure was 3726.0%, 241277.0% down from the prior year.
  • Net Margin reached 21.59% in Q3 2025 per FBIO's latest filing, down from 81.37% in the prior quarter.
  • Across five years, Net Margin topped out at 81.37% in Q2 2025 and bottomed at 4049.22% in Q2 2022.
  • Average Net Margin over 5 years is 342.77%, with a median of 155.58% recorded in 2023.
  • Peak YoY movement for Net Margin: plummeted -380985bps in 2022, then skyrocketed 389364bps in 2023.
  • A 5-year view of Net Margin shows it stood at 341.05% in 2021, then soared by 48bps to 176.18% in 2022, then skyrocketed by 116bps to 28.31% in 2023, then decreased by -17bps to 23.53% in 2024, then fell by -8bps to 21.59% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 21.59% in Q3 2025, 81.37% in Q2 2025, and 96.77% in Q1 2025.